These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 18537181
1. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P. Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181 [Abstract] [Full Text] [Related]
2. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G. Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473 [Abstract] [Full Text] [Related]
3. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, Sartorelli MR, Angulo P. Hepatology; 2006 Aug; 44(2):458-65. PubMed ID: 16871574 [Abstract] [Full Text] [Related]
4. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Nobili V, Manco M, Devito R, Ciampalini P, Piemonte F, Marcellini M. Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1553-61. PubMed ID: 17206944 [Abstract] [Full Text] [Related]
5. Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Vilar Gomez E, Rodriguez De Miranda A, Gra Oramas B, Arus Soler E, Llanio Navarro R, Calzadilla Bertot L, Yasells Garcia A, Del Rosario Abreu Vazquez M. Aliment Pharmacol Ther; 2009 Nov 15; 30(10):999-1009. PubMed ID: 19691668 [Abstract] [Full Text] [Related]
6. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, David E, Rizzetto M, Marchesini G. Am J Gastroenterol; 2005 May 15; 100(5):1082-90. PubMed ID: 15842582 [Abstract] [Full Text] [Related]
7. [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle]. Santomauro M, Paoli-Valeri M, Fernández M, Camacho N, Molina Z, Cicchetti R, Valeri L, Dávila de Campagnaro E, Arata-Bellabarba G. Endocrinol Nutr; 2012 May 15; 59(6):346-53. PubMed ID: 22717644 [Abstract] [Full Text] [Related]
8. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Hepatology; 2009 Jan 15; 49(1):80-6. PubMed ID: 19053049 [Abstract] [Full Text] [Related]
9. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, Königsrainer A, Königsrainer I, Kröber S, Niess A, Fritsche A, Häring HU, Stefan N. Gut; 2009 Sep 15; 58(9):1281-8. PubMed ID: 19074179 [Abstract] [Full Text] [Related]
10. Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E. D'Adamo E, Marcovecchio ML, Giannini C, de Giorgis T, Chiavaroli V, Chiarelli F, Mohn A. Free Radic Res; 2013 Mar 15; 47(3):146-53. PubMed ID: 23205728 [Abstract] [Full Text] [Related]
11. Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. Grønbæk H, Lange A, Birkebæk NH, Holland-Fischer P, Solvig J, Hørlyck A, Kristensen K, Rittig S, Vilstrup H. J Pediatr Gastroenterol Nutr; 2012 Feb 15; 54(2):223-8. PubMed ID: 21760546 [Abstract] [Full Text] [Related]
12. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Am J Gastroenterol; 2003 Nov 15; 98(11):2485-90. PubMed ID: 14638353 [Abstract] [Full Text] [Related]
13. Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study. Lee YM, Low HC, Lim LG, Dan YY, Aung MO, Cheng CL, Wee A, Lim SG, Ho KY. Gastrointest Endosc; 2012 Oct 15; 76(4):756-60. PubMed ID: 22840293 [Abstract] [Full Text] [Related]
14. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. Jin YJ, Kim KM, Hwang S, Lee SG, Ha TY, Song GW, Jung DH, Kim KH, Yu E, Shim JH, Lim YS, Lee HC, Chung YH, Lee Y, Suh DJ. J Gastroenterol Hepatol; 2012 Aug 15; 27(8):1341-7. PubMed ID: 22554085 [Abstract] [Full Text] [Related]
15. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. Pacifico L, Arca M, Anania C, Cantisani V, Di Martino M, Chiesa C. Nutr Metab Cardiovasc Dis; 2013 Oct 15; 23(10):1010-6. PubMed ID: 23018041 [Abstract] [Full Text] [Related]
20. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study. Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D. Int J Obes (Lond); 2008 Apr 15; 32(4):692-9. PubMed ID: 18071341 [Abstract] [Full Text] [Related] Page: [Next] [New Search]